More Liv-52 Research Studies and Clinical Trials
Hepatoprotective effects of Liv-52 on ethanol induced liver damage in rats: Liv-52 treatment was found to have protective effects on the activity of superoxide dismutase and the levels of glutathione. The results obtained from the study indicate hepatoprotective nature of Liv-52 which might be attributed to its ability to inhibit lipid peroxidation.
The effect of the heptoprotective agent LIV 52 on liver damage: Administration of LIV 52 can improve the subjective condition and clinical parameters in patients with liver damage, in particular in alcoholic liver damage and in steatosis.
Hepatoprotective effect of Liv-52 and kumaryasava on carbon tetrachloride induced hepatic damage in rats Results indicate that Liv-52 and kumaryasava have protective effect on hepatic enzyme induced due to CCl4 hepatotoxicity.
Effect of Liv.52, a herbal preparation, on absorption and metabolism of ethanol in humans Liv.52 enhanced the rate of absorption of ethanol and rapidly reduced acetaldehyde levels, which may explain its hepatoprotective effect on ethanol-induced liver damage.
Prevention of mercuric chloride induced histopathological changes in the small intestine of mice with LIV-52 Again, use of drug appeared useful. At least under laboratory conditions this herbal drug seems to reduce Hg-induced pathological changes in small intestine of mice.
Chemopreventive action of Liv. 52 on DMBA-induced papillomagenesis in skin of mice The cumulative number of papillomas was also reduced to 16 and 19 in animals treated with Liv. 52 at peri-initiational and post-initiational stages, respectively.
Miscellaneous research studies and clinical trials on efficacy of Liv-52
- Effect
of Liv.52 in digestive disorders among children (pdf)
Khrushcheva, N.A. and Safronova, L.E., State Medical Academy
based in Ural, Regional Children's Clinical Hospital, Ekaterinburg, Russia,
Capsule (2002): (XLI), 4, January / March.
- Use
of hepatoprotective agents in hepatomegaly syndrome in children:
An experience with Liv.52 Syrup (pdf)
Otilia Marginean, MD, PhD, Ioana Micle,
MD, PhD, Maria Lesovici, MD, PhD, Pediatric Hospital "Louis
Turcanu", Timisoara, Romania, Raluca Balean, MD, Budiu Ioana,
MD, County Hospital Nr. 1, Timisoara, Romania, and Edited by:
Kala Suhas Kulkarni, MD, MCPS Medical Advisor, R&D Center,
The Himalaya Drug Company, Bangalore, Karnataka, India, Medicine
Update (2002): (10), 8, 57.
- Physiological Icterus of the newborn and the role of Liv.52 (pdf)
Goel, S.P., Lecturer, Department of Pediatrics,
Garg, B.K., Professor and Head of the Department of Pediatrics
Sharma, D.K., Professor in the Department of Pediatrics, Upadhyay,
V.K., Lecturer in the Department of Pediatrics, L.L.R.M. Medical
College, Meerut, India, Probe (1994): (XXXIV), 1, 45.
- Prevention
of mercuric chloride-induced histopathological changes in the
small intestine of mice with Liv.52 (pdf)
Johnson, V. and Rathore, H.S., Cell Biology
Unit, School of Studies in Zoology, Vikram University, Ujjain,
Madhya Pradesh, Indian Journal of Medical Sciences (1994): (48),
11, 253.
- Chemopreventive
action of Liv.52 on DMBA-induced papillomagenesis in skin of mice (pdf)
Ritu Prashar and Ashok Kumar, Department
of Zoology, University of Rajasthan, Jaipur, Rajasthan, Indian
Journal of Experimental Biology (1994): (32), Sep., 643.
- Evaluation
of the role of Liv.52 treatment in swiss albino mice during pre-
and post-natal development (pdf)
Saini, M.R., Sharma, K. and Kumar, A.,
Radiation Biology Laboratory, University of Rajasthan, Jaipur,
India, Probe (1994): (XXXIII), 4, 343.
- Cytogenetic
effects of Liv.52 on the male germline cells of poekilocerus pictus
(Acrididae: Orthoptera) (pdf)
Edward Gururaj, M. and Uma, O., Department
of Studies in Zoology, University of Mysore, Mysore, Karnataka,
Journal of Mysore University (1993): (33), 181.
- Role
of Liv.52 and Geriforte as general metabolic tonics in drug addicts (pdf)
Jain, N.C., Government Rajindera Medical
College and Hospital, Patiala, Singal, R.P., Dayanand Hospital,
Ludhiana, Punjab, and Shahi, S.R., S.S.M.D. Ayurvedic College
and Hospital, Moga, Punjab, Probe (1992): (XXXII), 1, 32.
- Absence
of teratogenic effect of Liv.52 in albino rats (pdf)
Singh, N., Verma, P. and Mishra, N., Upgraded
Department of Pharmacology and Therapeutics, K.G. Medical College,
Lucknow, Uttar Pradesh, Journal of Biological and Chemical Research
(1990): (9), 445.
- Inhibition
of clastogenic effect of radiation by Liv.52 in the bone marrow
of mice (pdf)
Ganesh Chandra Jagetia and Ganapathi,
N.G., Department of Radiobiology, Kasturba Medical College, Manipal,
Karnataka, Mutation Research (1989):
(224), 4, 507.
- Lack
of teratogenicity of Liv.52 (pdf)
Chauhan, B.L., Gurjar, P.A. and Kulkarni,
R.D., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra,
Probe (1988): (XXVIII), 1, 36.
- Liv.52
protection against radiation-induced abnormalities on mammalian
prenatal development (pdf)
Saini, M.R., Kumar, S., Department of
Zoology, University of Rajasthan, Jaipur, Rajasthan, and Saini,
N., Department of Paediatrics, E.S.I. Hospital, Jaipur, Rajasthan,
Radiobiology and Radiotherapy
(1985): (26), 3, 385.
- The
treatment of non-suppurative hepatic amoebiasis with Liv.52 as
an adjuvant to antiamoebic drugs (pdf)
Bose, S.L. and Rout, A.K., Department
of Medicine, S.C.B. Medical College, Cuttack, Orissa, Indian Medical
Journal (1983): 1, 3.
- Role
of Liv.52 in the treatment of pityriasis alba (pdf)
Chakraborty, A.K., G.T. Road, Kalitala,
Serampore, West Bengal, Capsule (1983): 1, 9.
- Liv.52
in burns cases (pdf)
Malla, C.N. and Surinder Singh, Medical
College and H.M.H.S. Hospital, Srinagar, Jammu and Kashmir, Probe
(1982): (XXII), 1, 24.
- Clinical
trial of Liv.52 in burns (pdf)
Parangusa Das, R.A., Vijayalakshmi, B.
and Subhashini, M.,Victoria Hospital, Bangalore, Karnataka, Probe
(1982): (XXI), 3, 192.
- Role
of Liv.52 in psychiatric illness (pdf)
Rustom N. Burjorjee, Calcutta Medical
Centre, London Street, Calcutta, West Bengal, Capsule (1982):
5, 98.
- A
case study on Liv.52 an adjuvant in diabetes mellitus (pdf)
Sinha, A.K., P.T.P.S. Hospital, Patralu,
District, Hazaribagh, Bihar, Capsule (1982): 8, 178.
- Effect
of Liv.52 on liver lipids (pdf)
Alok Saxena, Sharma, S.K. and Garg, N.K.,
Department of Biochemistry, Central Drug Research Institute, Lucknow,
Uttar Pradesh, Indian Journal of Experimental Biology (1980):
11, 1330.
- Potentiation
of barbiturate hypnosis in rats by Liv.52 (pdf)
Dhume, V.G., Goa Medical College, Panaji,
Goa, and Bijlani, C.J., T.N. Medical College, Bombay, Maharashtra,
The Clinician (1979): (43), 2, 59.
- Evaluation
of Liv.52 in the treatment of jaundice with pregnancy (pdf)
Arun Kumar Mitra and Abhik De, Calcutta
Medical College, West Bengal, Probe (1978): (XVII), 2, 143.
- Liv.52
in herpes-progenitalis (pdf)
Iswar Tanwani, Howrah Road, Deolali Cantonment,
Nasik District, Maharashtra, Journal of National Integrated Medical
Association (1976): (18), 3, 98.
- Effect
of Liv.52 on serum lipids in normal and patients suffering from
ischaemic heart disease (pdf)
Rao, C.R. and Subba Rao, A., Bowring and
Lady Curzon Hospital, Postgraduate and Research Institute, Bangalore,
Karnataka, Probe (1975): (XIV), 3, 177.
- Radioactive
Rose Bengal test of liver function – A preliminary report
of Liv.52 trial (pdf)
Rajagopal, K.R., Radio-Isotope Department,
Barnard Institute of Radiology, Government General Hospital, Madras,
Tamil Nadu, Probe (1974): (XIV), 1, 50.
- A
clinical study of the therapeutic efficacy of Liv.52 as an adjuvant
in the treatment of hepatic amoebiasis (pdf)
Sethi, J.P. and Suresh Meratwal, Department
of Medicine, S.M.S. Medical College and Attached Hospital, Jaipur,
Rajasthan, Probe (1973): (XII), 3, 129.
- Gastrointestinal
allergy treated with Liv.52 – A case report (pdf)
Tripathi, A.R., Department of Forensic
Medicine, Institute of Medical Services, Banaras Hindu University,
Varanasi, Uttar Pradesh, Capsule (1973): June/July, 30.
- Liv.52
in dermatology (pdf)
Behl, P.N., Skin Institute, Delhi, Probe
(1972): (XI), 2, 100.
- Therapy
of toxaemias of pregnancy (pdf)
Narone, J.N., and Raj Narone (Mrs.), Department
of Gynaecology and Obstetrics, Patna Medical College, Patna, Bihar,
Probe (1972): (XI), 2, 120.
- Some
studies on physiological jaundice of the new-born (pdf)
Srivastava, J.R., Bhalla, J.N. and Arora,
A., G.S.V.M. Medical College, Kanpur, Uttar Pradesh, Probe (1972):
(XII), 1, 4.
- Liv.52
in vitiligo (pdf)
Punshi, S.K. Consultant Dermatologist
and Abroal, S.K., Amravati, M.S., Probe (1970): (X), 1, 12.
- Studies
with Liv.52 (pdf)
Lala Surajnandan Prasad, Department of
Paediatrics, Patna University, Patna, Bihar and Devendra Tripathy,
Hospital for Children, Patna Medical College Hospital, Patna,
Bihar, Probe (1969): (IX), 1, 1.
- Metabolic
effect of an indigenous compound on sportsmen (pdf)
Mathur, D.N., The National Institute of
Sports, Patiala, Punjab, Probe (1969): (VIII), 4, 144.
- Liv.52
in general practice (pdf)
Shah, N.B., Malegaon City, Nasik, Maharashtra,
Probe (1969): (VIII), 3, 101.
- A
clinical study – Physiological jaundice in neonates (pdf)
Chafekar, V.D., Annapoornabai Maternity
and Nursing Home, Gadag, Karnataka, Probe (1968): (VII), 3, 85.
- Observations
on Liv.52 (pdf)
Patrao, S., B.Y.L. Nair Hospital and T.N.
Medical College, Bombay, Maharashtra, Journal of Indian Medical
Profession (1957): 8, 1878.
- Ascitis
due to liver deficiency treated with an indigenous drug (pdf)
Sule, C.R., Sathe, P.M., Koshy, M.C. and
Desphande, M.S., The Indian Practitioner (1956): (IX), 4, 357.
|
Home
